Molecular biomarkers of Graves' ophthalmopathy.
C. M. Longo, P. Higgins
semanticscholar +1 more source
Orbital Radiotherapy for Graves' Ophthalmopathy: Single Institutional Experience of Efficacy and Safety. [PDF]
La Rocca M +16 more
europepmc +1 more source
"Real-Life" Utility of the Graves' Ophthalmopathy-Quality of Life in a Multidisciplinary Thyroid Eye Disease Service. [PDF]
Virdee S, Moledina M, Lee V.
europepmc +1 more source
Gina-Eva Görtz +6 more
semanticscholar +1 more source
Medial wall orbital decompression surgery for the treatment of Graves' ophthalmopathy: follow-up results in a single medical center. [PDF]
Ben Ishai M +5 more
europepmc +1 more source
Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves' Disease and Graves' Ophthalmopathy. [PDF]
Ke C +10 more
europepmc +1 more source
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy
M. Moleti +10 more
semanticscholar +1 more source
Study on the correlation between serum IgG4/IgG levels and the development of Graves' ophthalmopathy. [PDF]
Deng Y +8 more
europepmc +1 more source
Age and Clinical Activity Score (CAS): Key Predictive Factors for Non-shrinking Extraocular Muscles in Graves' Ophthalmopathy After Retrobulbar Injection of Glucocorticoids (GCs). [PDF]
Xiang Y, Li R, Zhao G, Jiang F, Yang J.
europepmc +1 more source

